Karaciğer Hastalıklarında Anestezi

Asrani SK, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151-171. doi:10.1016/j.jhep.2018.09.014

Starczewska MH, Mon W, Shirley P. Anaesthesia in patients with liver disease. Curr Opin Anaesthesiol. 2017;30(3):392-398. doi:10.1097/ACO.0000000000000470

Chen G, Cheung R, Tom JW. Hepatitis: Sedation and Anesthesia Implications. Anesth Prog. 2017;64(2):106-118. doi:10.2344/anpr-64-02-13

Spring A, Saran JS, McCarthy S, et al. Anesthesia for the Patient with Severe Liver Failure. Anesthesiol Clin. 2020;38(1):35-50. doi:10.1016/j.anclin.2019.10.002

Montomoli J, Erichsen R, Christiansen CF, et al. Liver disease and 30-day mortality after colorectal cancer surgery: a Danish population-based cohort study. BMC Gastroenterol. 2013;13:66. doi:10.1186/1471-230X-13-66

Ahdout J, Nurok M. Anesthesia Patients with Concomitant Cardiac and Hepatic Dysfunction. Anesthesiol Clin. 2016;34(4):731-745. doi:10.1016/j.anclin.2016.06.008

Neeff H, Mariaskin D, Spangenberg HC, et al. Perioperative mortality after non-hepatic general surgery in patients with liver cirrhosis: an analysis of 138 operations in the 2000s using Child and MELD scores. J Gastrointest Surg. 2011;15(1):1-11. doi:10.1007/s11605-010-1366-9

Telem DA, Schiano T, Goldstone R, et al. Factors that predict outcome of abdominal operations in patients with advanced cirrhosis. Clin Gastroenterol Hepatol. 2010;8(5):451-e58. doi:10.1016/j.cgh.2009.12.015

Brentjens TE, Chadha R. Anesthesia for the Patient with Concomitant Hepatic and Renal Impairment. Anesthesiol Clin. 2016;34(4):645-658. doi:10.1016/j.anclin.2016.06.002

Forkin KT, Colquhoun DA, Nemergut EC, et al. The Coagulation Profile of End-Stage Liver Disease and Considerations for Intraoperative Management. Anesth Analg. 2018;126(1):46-61. doi:10.1213/ANE.0000000000002394

Raval Z, Harinstein ME, Skaro AI, et al. Cardiovascular risk assessment of the liver transplant candidate. J Am Coll Cardiol. 2011;58(3):223-231. doi:10.1016/j.jacc.2011.03.026

Kalaitzakis E, Rosengren A, Skommevik T, et al. Coronary artery disease in patients with liver cirrhosis. Dig Dis Sci. 2010;55(2):467-475. doi:10.1007/s10620-009-0738-z

Pandey CK, Karna ST, Pandey VK, et al. Perioperative risk factors in patients with liver disease undergoing non-hepatic surgery. World J Gastrointest Surg. 2012;4(12):267-274. doi:10.4240/wjgs.v4.i12.267

Mcclain RL, Ramakrishna H, Aniskevich S III, et al. Anesthetic pharmacology and perioperative considerations for the end stage liver disease patient. Curr Clin Pharmacol. 2015;10(1):35-46. doi:10.2174/1574884709666140212110036

Hartleb M, Gutkowski K. Kidneys in chronic liver diseases. World J Gastroenterol. 2012;18(24):3035-3049. doi:10.3748/wjg.v18.i24.3035

Lin CS, Lin SY, Chang CC, et al. Postoperative adverse outcomes after non-hepatic surgery in patients with liver cirrhosis. Br J Surg. 2013;100(13):1784-1790. doi:10.1002/bjs.9312

Chaney A. A Review for the Practicing Clinician: Hepatorenal Syndrome, a Form of Acute Kidney Injury, in Patients with Cirrhosis. Clin Exp Gastroenterol. 2021;14:385-396. doi:10.2147/CEG.S323778

Ginès P, Guevara M, Arroyo V, et al. Hepatorenal syndrome. Lancet. 2003;362(9398):1819-1827. doi:10.1016/S0140-6736(03)14903-3

Facciorusso A, Chandar AK, Murad MH, et al. Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol. 2017;2(2):94-102. doi:10.1016/S2468-1253(16)30157-1

Møller S, Bendtsen F. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis. Liver Int. 2018;38(4):570-580. doi:10.1111/liv.13589

Møller S, Danielsen KV, Wiese S, et al. An update on cirrhotic cardiomyopathy. Expert Rev Gastroenterol Hepatol. 2019;13(5):497-505. doi:10.1080/17474124.2019.1587293

Desai MS, Mathur B, Eblimit Z, et al. Bile acid excess induces cardiomyopathy and metabolic dysfunctions in the heart. Hepatology. 2017;65(1):189-201. doi:10.1002/hep.28890

Fouad YM, Yehia R. Hepato-cardiac disorders. World J Hepatol. 2014;6(1):41-54. doi:10.4254/wjh.v6.i1.41

Toma L, Stanciu AM, Zgura A, et al. Electrocardiographic Changes in Liver Cirrhosis-Clues for Cirrhotic Cardiomyopathy. Medicina (Kaunas). 2020;56(2):68. Published 2020 Feb 10. doi:10.3390/medicina56020068

Kim SM, George B, Alcivar-Franco D, et al. QT prolongation is associated with increased mortality in end stage liver disease. World J Cardiol. 2017;9(4):347-354. doi:10.4330/wjc.v9.i4.347

Bhutani S, Tobis J, Gevorgyan R, et al. Accuracy of stress myocardial perfusion imaging to diagnose coronary artery disease in end stage liver disease patients. Am J Cardiol. 2013;111(7):1057-1061. doi:10.1016/j.amjcard.2012.12.023

Abeysundara L, Mallett SV, Clevenger B. Point-of-Care Testing in Liver Disease and Liver Surgery. Semin Thromb Hemost. 2017;43(4):407-415. doi:10.1055/s-0037-1599154

Raevens S, Geerts A, Van Steenkiste C, et al. Hepatopulmonary syndrome and portopulmonary hypertension: recent knowledge in pathogenesis and overview of clinical assessment. Liver Int. 2015;35(6):1646-1660. doi:10.1111/liv.12791

Aldenkortt F, Aldenkortt M, Caviezel L, et al. Portopulmonary hypertension and hepatopulmonary syndrome. World J Gastroenterol. 2014;20(25):8072-8081. doi:10.3748/wjg.v20.i25.8072

Yigit IP, Hacievliyagil SS, Seckin Y, et al. The relationship between severity of liver cirrhosis and pulmonary function tests. Dig Dis Sci. 2008;53(7):1951-1956. doi:10.1007/s10620-007-0100-2

Mazzeo AT, Lucanto T, Santamaria LB. Hepatopulmonary syndrome: a concern for the anesthetist? Pre-operative evaluation of hypoxemic patients with liver disease. Acta Anaesthesiol Scand. 2004;48(2):178-186. doi:10.1111/j.0001-5172.2004.00282.x

Gandhi KD, Taweesedt PT, Sharma M, et al. Hepatopulmonary syndrome: An update. World J Hepatol. 2021;13(11):1699-1706. doi:10.4254/wjh.v13.i11.1699

Diaz GC, O'Connor MF, Renz JF. Anesthesia for Patients with Concomitant Hepatic and Pulmonary Dysfunction. Anesthesiol Clin. 2016;34(4):797-808. doi:10.1016/j.anclin.2016.06.012

Bauer M, Fuhrmann V, Wendon J. Pulmonary complications in liver disease. Intensive Care Med. 2019;45(10):1433-1435. doi:10.1007/s00134-019-05721-y

Gómez FP, Martínez-Pallí G, Barberà JA, et al. Gas exchange mechanism of orthodeoxia in hepatopulmonary syndrome. Hepatology. 2004;40(3):660-666. doi:10.1002/hep.20358

Kawut SM, Krowka MJ, Trotter JF, et al. Clinical risk factors for portopulmonary hypertension. Hepatology. 2008;48(1):196-203. doi:10.1002/hep.22275

Adelmann D, Kronish K, Ramsay MA. Anesthesia for Liver Transplantation. Anesthesiol Clin. 2017;35(3):491-508. doi:10.1016/j.anclin.2017.04.006

Jawan B, Wang CH, Chen CL, et al. Review of anesthesia in liver transplantation. Acta Anaesthesiol Taiwan. 2014;52(4):185-196. doi:10.1016/j.aat.2014.09.004

Liu LL, Niemann CU. Intraoperative management of liver transplant patients. Transplant Rev (Orlando). 2011;25(3):124-129. doi:10.1016/j.trre.2010.10.006